Cleared Traditional

K981989 - THE WAVE DIGITAL PHACO SYSTEM

K981989 is an FDA 510(k) clearance for THE WAVE DIGITAL PHACO SYSTEM, manufactured by Circuit Tree. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 81-day FDA review.

K981989 · Circuit Tree · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1998
Decision
81d
Days
Class 2
Risk

K981989 is an FDA 510(k) clearance for the THE WAVE DIGITAL PHACO SYSTEM. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Circuit Tree (San Juan Capistrano, US). The FDA issued a Cleared decision on August 25, 1998 after a review of 81 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Circuit Tree devices

FDA 510(k) Submission Details - K981989

510(k) Number K981989 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 05, 1998
Decision Date August 25, 1998
Days to Decision 81 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 110d · This submission: 81d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 165
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K981989.
SURGE-FREE ASPIRATION ADAPTER
K020734 · Staar Surgical Co. · May 2002
MOJAVE CATARACT EXTRACTION SYSTEM
K003638 · Allergan, Inc. · Feb 2001
FIBRA-SONICS PHACO III OR IIIP FRAGMENTATION SYSTEM
K984143 · Fibra Sonics, Inc. · Feb 1999
TURBOSONICS LIMITED REUSE ULTRASONIC TIP
K981103 · Alcon Laboratories · Jun 1998
QUITETIP
K981109 · Paradigm Medical Industries, Inc. · Jun 1998
SYNTEC VITMAN
K980480 · Syntec, Inc. · May 1998